Informations générales (source: ClinicalTrials.gov)
Evaluation of the Best Treatment in Terms of Quality of Life for Patients Having a Brain Metastasis
Interventional
N/A
University Hospital, Caen (Voir sur ClinicalTrials)
mars 2020
mars 2024
14 septembre 2025
Main Goal : evaluation of quality of life for patient having a brain metastasis and
allowed to have either surgery and radiosurgery of the surgical site or only
hypofractionned radiosurgery on the lesion.
second objectives : evaluation of the local control of the disease evaluation of the
overall survival interval without progression evaluation of the medico economic
performance of each treatment protocol neuro cognitive evaluation at the end of the
protocol
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CHU CAEN - 14000 - Caen - France | Evelyne Emery, MD PhD | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- eligible for both treatments options OMS status <3 primary cancer with no evolution
brain metastasis < 3cm ou giving symtoms patient with informed consent patient
affilated to french social security
- eligible for both treatments options OMS status <3 primary cancer with no evolution
brain metastasis < 3cm ou giving symtoms patient with informed consent patient
affilated to french social security
- OMS > 3 More than 3 brain metastasis brain metastasis already treated with
hypofractionned radiosurgery